Thu, Aug 21, 2014, 2:40 PM EDT - U.S. Markets close in 1 hr 20 mins

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • lior.elkayam lior.elkayam Jul 18, 2013 10:37 PM Flag

    Comments from a cardiologist

    1. Concern of omega-3 causing prostate cancer are exaggerated. While I think the overblown publicity will hurt OTC fish oil sales it should not hurt prescription sales because any MD who believes their patient should be on Vascepa will easily explain to their concerned patient that a post-hoc analysis of a completely unrelated study is worthless and does not establish a cause and effect relationship.

    2. I believe tomorrow's script numbers will well exceed 5k. I for one have prescribed it several times this week and am looking forward to FDA approval for the ANCHOR indication.

    3. Another company to look at is ACST. While it has had a tremendous run recently it is expecting to release the first of two phase II trials next month. If these studies prove their animal studies are correct, that is that their krill oil, Capre lowers LDL, Tg and raises HDL we are talking about a potential $5-7 billion company. Current market cap $270 mil.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
AMRN
1.805-0.015(-0.82%)2:39 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.